Skip to main content
Top
Published in: BMC Urology 1/2019

Open Access 01-12-2019 | Trospium | Research article

Expression of components of the urothelial cholinergic system in bladder and cultivated primary urothelial cells of the pig

Authors: Dorothea Leonhäuser, Jasmin Kranz, Regina Leidolf, Patrick Arndt, Ulrich Schwantes, Joachim Geyer, Joachim O. Grosse

Published in: BMC Urology | Issue 1/2019

Login to get access

Abstract

Background

Porcine urinary bladders are widely used for uro-pharmacological examinations due to their resemblance to the human organ. However, characterisations of the porcine urothelium at the molecular level are scarce up to now. As it has become clear over the last years that this tissue plays an important role in the signaling-pathways of the bladder, we examined whether the transporter and receptor pattern (with focus on the transmitter acetylcholine) is comparable to the human urothelium. With regard to in vitro studies, we also investigated if there is a difference between the native tissue and cultivated primary urothelial cells in culture.

Methods

Urothelium from German Landrace and Göttingen Minipig bladders was collected. One part of the German Landrace tissue was used for cultivation, and different passages of the urothelial cells were collected. The actual mRNA expression of different transporters and receptors was examined via quantitative real-time PCR. These included the vesicular acetylcholine transporter (VAChT), the choline acetyl transferase (ChAT), organic cation transporters 1–3 (OCT1–3), organic anion transporting polypeptide 1A2 (OATP1A2), P-glycoprotein (ABCB1), the carnitine acetyl-transferase (CarAT), as well as the muscarinic receptors 1–5 (M1–5).

Results

There is a strong qualitative resemblance between the human and the porcine urothelium with regard to the investigated cholinergic receptors, enzymes and transporters. CarAT, OCT1–3, OATP1A2 and ABCB1 could be detected in the urothelium of both pig races. Moreover, all 5 M-receptors were prominent with an emphasis on M2 and M3. VAChT and ChAT could not be detected at all. Cultures of the derived urothelial cells showed decreased expression of all targets apart from ABCB1 and CarAT.

Conclusions

Based on the expression pattern of receptors, transporters and enzymes of the cholinergic system, the porcine urinary bladder can be regarded as a good model for pharmacological studies. However, cultivation of primary urothelial cells resulted in a significant drop in mRNA expression of the targets. Therefore, it can be concluded that the intact porcine urothelium, or the whole pig bladder, may be appropriate models for studies with anticholinergic drugs, whereas cultivated urothelial cells have some limitation due to significant changes in the expression levels of relevant targets.
Literature
1.
go back to reference Templeman L, Chapple CR, Chess-Williams R. Urothelium derived inhibitory factor and cross-talk among receptors in the trigone of the bladder of the pig. J Urol. 2002;167(2):742–5.PubMedCrossRef Templeman L, Chapple CR, Chess-Williams R. Urothelium derived inhibitory factor and cross-talk among receptors in the trigone of the bladder of the pig. J Urol. 2002;167(2):742–5.PubMedCrossRef
2.
go back to reference Yamanishi T, Chapple CR, Yasuda K, Chess-Williams R. The role of M-2-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro. Br J Pharmacol. 2000;131(7):1482–8.PubMedPubMedCentralCrossRef Yamanishi T, Chapple CR, Yasuda K, Chess-Williams R. The role of M-2-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro. Br J Pharmacol. 2000;131(7):1482–8.PubMedPubMedCentralCrossRef
3.
go back to reference Parsons BA, Drake MJ, Gammie A, Fry CH, Vahabi B. The validation of a functional, isolated pig bladder model for physiological experimentation. Front Pharmacol. 2012;3:52.PubMedPubMedCentralCrossRef Parsons BA, Drake MJ, Gammie A, Fry CH, Vahabi B. The validation of a functional, isolated pig bladder model for physiological experimentation. Front Pharmacol. 2012;3:52.PubMedPubMedCentralCrossRef
4.
go back to reference Huppertz ND, Tolba RH, Grosse JO. Micturition in Gottingen minipigs: first reference invivo data for urological research and review of literature. Lab Anim. 2015;49(4):336–44.PubMedCrossRef Huppertz ND, Tolba RH, Grosse JO. Micturition in Gottingen minipigs: first reference invivo data for urological research and review of literature. Lab Anim. 2015;49(4):336–44.PubMedCrossRef
5.
go back to reference Bode G, Clausing P, Gervais F, Loegsted J, Luft J, Nogues V, et al. The utility of the minipig as an animal model in regulatory toxicology. J Pharmacol Toxicol Methods. 2010;62(3):196–220.PubMedCrossRef Bode G, Clausing P, Gervais F, Loegsted J, Luft J, Nogues V, et al. The utility of the minipig as an animal model in regulatory toxicology. J Pharmacol Toxicol Methods. 2010;62(3):196–220.PubMedCrossRef
6.
go back to reference Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int. 2007;100(5):987–1006.PubMedCrossRef Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int. 2007;100(5):987–1006.PubMedCrossRef
7.
go back to reference Andersson KE, Yoshida M. Antimuscarinics and the overactive detrusor - which is the main mechanism of action? Eur Urol. 2003;43(1):1–5.PubMedCrossRef Andersson KE, Yoshida M. Antimuscarinics and the overactive detrusor - which is the main mechanism of action? Eur Urol. 2003;43(1):1–5.PubMedCrossRef
8.
go back to reference Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol. 2006;148(5):565–78.PubMedPubMedCentralCrossRef Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol. 2006;148(5):565–78.PubMedPubMedCentralCrossRef
9.
go back to reference Finney SM, Andersson KE, Gillespie JI, Stewart LH. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int. 2006;98(3):503–7.PubMedCrossRef Finney SM, Andersson KE, Gillespie JI, Stewart LH. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int. 2006;98(3):503–7.PubMedCrossRef
10.
go back to reference Goepel M, Gronewald A, Krege S, Michel MC. Muscarinic receptor subtypes in porcine detrusor: comparison with humans and regulation by bladder augmentation. Urol Res. 1998;26(2):149–54.PubMedCrossRef Goepel M, Gronewald A, Krege S, Michel MC. Muscarinic receptor subtypes in porcine detrusor: comparison with humans and regulation by bladder augmentation. Urol Res. 1998;26(2):149–54.PubMedCrossRef
11.
go back to reference Sellers DJ, Yamanishi T, Chapple CR, Couldwell C, Yasuda K, Chess-Williams R. M-3 muscarinic receptors but not M-2 mediate contraction of the porcine detrusor muscle in vitro. J Auton Pharmacol. 2000;20(3):171–6.PubMedCrossRef Sellers DJ, Yamanishi T, Chapple CR, Couldwell C, Yasuda K, Chess-Williams R. M-3 muscarinic receptors but not M-2 mediate contraction of the porcine detrusor muscle in vitro. J Auton Pharmacol. 2000;20(3):171–6.PubMedCrossRef
12.
go back to reference Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E. Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol. 2005;144(8):1089–99.PubMedPubMedCentralCrossRef Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E. Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol. 2005;144(8):1089–99.PubMedPubMedCentralCrossRef
13.
go back to reference Bschleipfer T, Schukowski K, Weidner W, Grando SA, Schwantes U, Kummer W, et al. Expression and distribution of cholinergic receptors in the human urothelium. Life Sci. 2007;80(24–25):2303–7.PubMedCrossRef Bschleipfer T, Schukowski K, Weidner W, Grando SA, Schwantes U, Kummer W, et al. Expression and distribution of cholinergic receptors in the human urothelium. Life Sci. 2007;80(24–25):2303–7.PubMedCrossRef
14.
go back to reference Tyagi S, Tyagi P, Van-le S, Yoshimura N, Chancellor MB, de Miguel F. Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor. J Urol. 2006;176(4).PubMedCrossRef Tyagi S, Tyagi P, Van-le S, Yoshimura N, Chancellor MB, de Miguel F. Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor. J Urol. 2006;176(4).PubMedCrossRef
15.
go back to reference Lips KS, Wunsch J, Zarghooni S, Bschleipfer T, Schukowski K, Weidner W, et al. Acetylcholine and molecular components of its synthesis and release machinery in the urothelium. Eur Urol. 2007;51(4):1042–53.PubMedCrossRef Lips KS, Wunsch J, Zarghooni S, Bschleipfer T, Schukowski K, Weidner W, et al. Acetylcholine and molecular components of its synthesis and release machinery in the urothelium. Eur Urol. 2007;51(4):1042–53.PubMedCrossRef
16.
go back to reference Wenge B, Geyer J, Bönisch H. The anticholinergic drugs oxybutynin and trospium chloride are substrates of the human organic cation transporters. In: Naunyn-Schmiedeberg’s archives of pharmacology, vol. 383. Berlin Heidelberg: Springer; 2010. p. 203–8. Wenge B, Geyer J, Bönisch H. The anticholinergic drugs oxybutynin and trospium chloride are substrates of the human organic cation transporters. In: Naunyn-Schmiedeberg’s archives of pharmacology, vol. 383. Berlin Heidelberg: Springer; 2010. p. 203–8.
17.
go back to reference Franke RM, Scherkenbach LA, Sparreboom A. Pharmacogenetics of the organic anion transporting polypeptide 1A2. Pharmacogenomics. 2009;10(3):339–44.PubMedCrossRef Franke RM, Scherkenbach LA, Sparreboom A. Pharmacogenetics of the organic anion transporting polypeptide 1A2. Pharmacogenomics. 2009;10(3):339–44.PubMedCrossRef
18.
go back to reference Clifford SC, Neal DE, Lunec J. High level expression of the multidrug resistance (MDRI) gene in the normal bladder urothelium: a potential involvement in protection against carcinogens? Carcinogenesis. 1996;17(3):601–4.PubMedCrossRef Clifford SC, Neal DE, Lunec J. High level expression of the multidrug resistance (MDRI) gene in the normal bladder urothelium: a potential involvement in protection against carcinogens? Carcinogenesis. 1996;17(3):601–4.PubMedCrossRef
19.
go back to reference Bexten M, Oswald S, Grube M, Jia J, Graf T, Zimmermann U, et al. Expression of drug transporters and drug metabolizing enzymes in the bladder Urothelium in man and affinity of the bladder spasmolytic Trospium chloride to transporters likely involved in its pharmacokinetics. Mol Pharm. 2015;12(1):171–8.PubMedCrossRef Bexten M, Oswald S, Grube M, Jia J, Graf T, Zimmermann U, et al. Expression of drug transporters and drug metabolizing enzymes in the bladder Urothelium in man and affinity of the bladder spasmolytic Trospium chloride to transporters likely involved in its pharmacokinetics. Mol Pharm. 2015;12(1):171–8.PubMedCrossRef
20.
go back to reference Leonhäuser D, Vogt M, Tolba RH, Grosse JO. Potential in two types of collagen scaffolds for urological tissue engineering applications - are there differrences in growth behaviour of juvenile and adult vesical cells? J Biomater Appl. 2016;30(7):961–73.PubMedCrossRef Leonhäuser D, Vogt M, Tolba RH, Grosse JO. Potential in two types of collagen scaffolds for urological tissue engineering applications - are there differrences in growth behaviour of juvenile and adult vesical cells? J Biomater Appl. 2016;30(7):961–73.PubMedCrossRef
21.
go back to reference Birder LA. More than just a barrier: urothelium as a drug target for urinary bladder pain. Am J Physiol Renal Physiol. 2005;289(3):F489–F95.PubMedCrossRef Birder LA. More than just a barrier: urothelium as a drug target for urinary bladder pain. Am J Physiol Renal Physiol. 2005;289(3):F489–F95.PubMedCrossRef
23.
go back to reference Geyer J, Gavrilova O, Petzinger E. The role of P-glycoprotein in limiting brain penetration of the peripherally acting anticholinergic overactive bladder drug Trospium chloride. Drug Metab Dispos. 2009;37(7):1371–4.PubMedCrossRef Geyer J, Gavrilova O, Petzinger E. The role of P-glycoprotein in limiting brain penetration of the peripherally acting anticholinergic overactive bladder drug Trospium chloride. Drug Metab Dispos. 2009;37(7):1371–4.PubMedCrossRef
24.
go back to reference Oswald S, Grube M, Siegmund W, Kroemer HK. Transporter-mediated uptake into cellular compartments. Xenobiotica. 2007;37(10–11):1171–95.PubMedCrossRef Oswald S, Grube M, Siegmund W, Kroemer HK. Transporter-mediated uptake into cellular compartments. Xenobiotica. 2007;37(10–11):1171–95.PubMedCrossRef
25.
go back to reference Mukerji G, Yiangou Y, Grogono J, Underwood J, Agarwal SK, Khullar V, et al. Localization of M-2 and M-3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol. 2006;176(1):367–73.PubMedCrossRef Mukerji G, Yiangou Y, Grogono J, Underwood J, Agarwal SK, Khullar V, et al. Localization of M-2 and M-3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol. 2006;176(1):367–73.PubMedCrossRef
26.
go back to reference Gupta GN, Lu SG, Gold MS, Chail TC. Bladder urothelial cells from patients with interstitial cystitis have an increased sensitivity to carbachol. Neurourol Urodyn. 2009;28(8):1022–7.PubMedPubMedCentralCrossRef Gupta GN, Lu SG, Gold MS, Chail TC. Bladder urothelial cells from patients with interstitial cystitis have an increased sensitivity to carbachol. Neurourol Urodyn. 2009;28(8):1022–7.PubMedPubMedCentralCrossRef
28.
go back to reference Bollen P, Ellegaard L. The Gottingen minipig in pharmacology and toxicology. Pharmacol Toxicol. 1997;80:3–4.PubMedCrossRef Bollen P, Ellegaard L. The Gottingen minipig in pharmacology and toxicology. Pharmacol Toxicol. 1997;80:3–4.PubMedCrossRef
29.
go back to reference Zarghooni S, Wunsch J, Bodenbenner M, Brueggmann D, Grando SA, Schwantes U, et al. Expression of muscarinic and nicotinic acetylcholine receptors in the mouse urothelium. Life Sci. 2007;80(24–25).PubMedCrossRef Zarghooni S, Wunsch J, Bodenbenner M, Brueggmann D, Grando SA, Schwantes U, et al. Expression of muscarinic and nicotinic acetylcholine receptors in the mouse urothelium. Life Sci. 2007;80(24–25).PubMedCrossRef
30.
go back to reference Hanna-Mitchell AT, Beckel JM, Barbadora S, Kanai AJ, de Groat WC, Birder LA. Non-neuronal acetylcholine and urinary bladder urothelium. Life Sci. 2007;80(24–25):2298–302.PubMedPubMedCentralCrossRef Hanna-Mitchell AT, Beckel JM, Barbadora S, Kanai AJ, de Groat WC, Birder LA. Non-neuronal acetylcholine and urinary bladder urothelium. Life Sci. 2007;80(24–25):2298–302.PubMedPubMedCentralCrossRef
31.
go back to reference Matsumoto Y, Miyazato M, Furuta A, Torimoto K, Hirao Y, Chancellor MB, et al. Differential roles of M2 and M3 muscarinic receptor subtypes in modulation of bladder afferent activity in rats. Urology. 2010;75(4):862–7.PubMedCrossRef Matsumoto Y, Miyazato M, Furuta A, Torimoto K, Hirao Y, Chancellor MB, et al. Differential roles of M2 and M3 muscarinic receptor subtypes in modulation of bladder afferent activity in rats. Urology. 2010;75(4):862–7.PubMedCrossRef
32.
go back to reference Nandigama R, Ibanez-Tallon I, Lips KS, Schwantes U, Kummer W, Bschleipfer T. Expression of nicotinic acetylcholine receptor subunit mRNA in mouse bladder afferent neurons. Neuroscience. 2013;229:27–35.PubMedCrossRef Nandigama R, Ibanez-Tallon I, Lips KS, Schwantes U, Kummer W, Bschleipfer T. Expression of nicotinic acetylcholine receptor subunit mRNA in mouse bladder afferent neurons. Neuroscience. 2013;229:27–35.PubMedCrossRef
33.
go back to reference Williams NA, Lee KM, Allender CJ, Bowen JL, Gumbleton M, Harrah T, et al. Investigating detrusor muscle concentrations of oxybutynin after Intravesical delivery in an ex vivo porcine model. J Pharm Sci. 2015;104(7):2233–40.PubMedCrossRef Williams NA, Lee KM, Allender CJ, Bowen JL, Gumbleton M, Harrah T, et al. Investigating detrusor muscle concentrations of oxybutynin after Intravesical delivery in an ex vivo porcine model. J Pharm Sci. 2015;104(7):2233–40.PubMedCrossRef
Metadata
Title
Expression of components of the urothelial cholinergic system in bladder and cultivated primary urothelial cells of the pig
Authors
Dorothea Leonhäuser
Jasmin Kranz
Regina Leidolf
Patrick Arndt
Ulrich Schwantes
Joachim Geyer
Joachim O. Grosse
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Trospium
Published in
BMC Urology / Issue 1/2019
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-019-0495-z

Other articles of this Issue 1/2019

BMC Urology 1/2019 Go to the issue